MEDS in America Act

The MEDS in America Act, also known as Bill 117 hr 5993, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the rising costs of prescription medications in the United States.

One key provision of the MEDS in America Act is the establishment of a Prescription Drug Affordability Board. This board would be responsible for setting limits on the prices of certain prescription drugs in order to make them more affordable for consumers. The board would also have the authority to negotiate prices with drug manufacturers in order to lower costs.

Another important aspect of the bill is the creation of a Prescription Drug Affordability Fund. This fund would provide financial assistance to individuals who are struggling to afford their prescription medications. The fund would be funded through a combination of government appropriations and contributions from drug manufacturers. Additionally, the MEDS in America Act includes measures to increase transparency in the pharmaceutical industry. Drug manufacturers would be required to disclose information about the costs of producing their medications, as well as any financial assistance programs they offer to consumers. Overall, the MEDS in America Act aims to address the issue of rising prescription drug costs in the United States through a combination of price controls, financial assistance programs, and increased transparency in the pharmaceutical industry. It is currently being debated in Congress, and its ultimate fate remains uncertain.